EUIPO trademark

DICERNA PHARMACEUTICALS

RegisteredEUIPOWord markClass 5Class 42

"DICERNA PHARMACEUTICALS" is a word mark owned by Dicerna Pharmaceuticals, Inc., filed at the EUIPO on November 8, 2018. It is registered and covers classes 5 and 42.

View Dicerna Pharmaceuticals, Inc. portfolio Get this data via the API

Data current as of March 22, 2019Official EUIPO record

DICERNA PHARMACEUTICALS

Word mark as filed with the EUIPO

Status: Registered; Since March 22, 2019
Filed: November 8, 2018
Registered: March 21, 2019
Expires: November 8, 2028
Application no.: 017982462
Registration no.: 017982462
Office: EUIPO; European Union Intellectual Property Office
Mark type: Word mark; 2 classes

Ownership

Who owns DICERNA PHARMACEUTICALS

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Dicerna Pharmaceuticals, Inc.

55 trademarks in the portfolioView company

Representative

HGF B.V.

HGF B.V

Goods and services

What the mark covers

The products and services DICERNA PHARMACEUTICALS is filed for, grouped by Nice class.

05Class 5 · Pharmaceuticals
Pharmaceutical preparations for the treatment of various diseases, namely, rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, cancers, and viral infections; Oligonucleotide compounds for use in the targeted delivery of RNAi therapy; Pharmaceutical preparations for use in targeted pharmaceutical therapies for the treatment of various diseases, namely, rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, cancers, and viral infections; Chemical compounds in the form of a molecular nanoparticle complex that act as a platform for the delivery of RNA-based drugs to biological cells; drug delivery agents consisting of oligonucleotide compounds that facilitate the delivery of a wide range of pharmaceutical based therapies
42Class 42 · Computer and Scientific Services
Research and development of oligonucleotide compounds for use in targeted pharmaceutical therapies for the treatment of various diseases, namely, rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, cancers, and viral infections; research and development of pharmaceutical preparations for the treatment of liver-based disorders; research and development of oligonucleotide compounds for targeted gene silencing; scientific research and development; scientific investigations for medical purposes; providing medical and scientific research information in the field of pharmaceuticals and clinical trials

History

What has happened so far

Steps recorded by the EUIPO, newest first.

September 3, 2026Bulletin 2026/167 Section C.2.1
February 26, 2024Bulletin 2024/039 Section C.2.1
January 7, 2021Bulletin 2021/003 Section C.2.2
January 4, 2021Bulletin 2021/001 Section C.2.2
April 12, 2019Bulletin 2019/072 Section C.2.2
March 22, 2019Bulletin 2019/057 Section B.1
December 12, 2018Bulletin 2018/236 Section A.1

FAQ

About DICERNA PHARMACEUTICALS

Who owns the trademark "DICERNA PHARMACEUTICALS"?

The EUIPO trademark "DICERNA PHARMACEUTICALS" (application 017982462) is owned by Dicerna Pharmaceuticals, Inc.

What is the status of "DICERNA PHARMACEUTICALS"?

Its status at the EUIPO is: registered.

When was "DICERNA PHARMACEUTICALS" registered?

It was registered on March 21, 2019 and is due to expire on November 8, 2028.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull DICERNA PHARMACEUTICALS and marks like it into your own product with one request.

GET/v1/trademarks/{id}
The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/events
Every step in the office history
GET/v1/proceedings?trademark_id={id}
Oppositions and cancellations against the mark

Get API key View docs

GET /v1/trademarks/{id}

ID=tm_019d4547-811b-75af-af9f-59990ff6e8ad
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"

Response

{
  "id": "tm_019d4547-811b-75af-af9f-59990ff6e8ad",
  "object": "trademark",
  "mark_text": "DICERNA PHARMACEUTICALS",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "EM",
  "application_number": "017982462",
  "filing_date": "2018-11-08",
  "nice_classes": [
    5,
    42
  ],
  "owners": [
    {
      "name": "Dicerna Pharmaceuticals, Inc.",
      "entity_id": "ent_019ebbd3-862f-711a-8bfe-d2b68aad05fd"
    }
  ]
}